PrEP
Vacc
Registration Cohort
Get Involved
News
About
Contact
Member's Area
Back
Latest News
News by partner
In the Media
Journal Publications List
Research Dissemination
News Archive
Back
Partners
Organisation and Governance
Our Funders
FAQs
PrEP
Vacc
Registration Cohort
Get Involved
News
Latest News
News by partner
In the Media
Journal Publications List
Research Dissemination
News Archive
About
Partners
Organisation and Governance
Our Funders
FAQs
Contact
Member's Area
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024
News from National Institute for Medical Research - Mbeya Medical Research Centre
Featured
Aug 5, 2024
FAQs for PrEPVacc's vaccine result
Aug 5, 2024
Aug 5, 2024
Jul 23, 2024
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Jul 23, 2024
Jul 23, 2024
Jan 11, 2024
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
Jan 11, 2024
Jan 11, 2024
Dec 4, 2023
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
Dec 4, 2023
Dec 4, 2023
Jun 9, 2023
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
Jun 9, 2023
Jun 9, 2023
Mar 31, 2023
Video to help inform PrEPVacc participants posted online
Mar 31, 2023
Mar 31, 2023
Nov 30, 2021
PrEPVacc featured in JIAS articles in Nov 2021
Nov 30, 2021
Nov 30, 2021
